Suchergebnisse - "Patel, Parul"

PubPharm (185)

1

Automated detection of methicillin-resistant Staphylococcus aureus with the MRSA CHROM imaging application on BD Kiestra Total Lab Automation System

enthalten in: Journal of clinical microbiology | 2024

von McElvania, E. | Mindel, S. | Lemstra, J. | +8

2

Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine : Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

enthalten in: HIV medicine | 2024

von Oka, S. | Holohan, V. | Shirasaka, T. | +13

3

The attitudes of dental therapists, dental therapy educators and dental therapy students in the South of England towards domiciliary dentistry : a qualitative study

enthalten in: British dental journal | 2024

von Emanuel, R. | Quach, J. | Patel, P. | +3

CommentIn: Br Dent J. 2024 Mar;236(5):390. - PMID 38459311

4

Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine : Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

enthalten in: HIV Medicine | 2024

von Oka, S. | Holohan, V. | Shirasaka, T. | +13

5

Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials

enthalten in: The Journal of infectious diseases | 2023

von Elliot, E. | Polli, J. | Patel, P. | +12

6

Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer : A Multicenter, Phase I/II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Krop, I. | Masuda, N. | Mukohara, T. | +22

7

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Yu, H. | Goto, Y. | Hayashi, H. | +26

8

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment : Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Orkin, C. | Schapiro, J. | Perno, C. | +20

9

Meta-analysis of primary care delivered buprenorphine treatment retention outcomes

enthalten in: The American journal of drug and alcohol abuse | 2023

von Cooper, R. | Edgerton, R. | Watson, J. | +10

10

Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR) : a randomised, open-label, phase 3b, non-inferiority trial

enthalten in: The lancet. HIV | 2023

von Ramgopal, M. | Castagna, A. | Cazanave, C. | +22

CommentIn: Lancet HIV. 2023 Sep;10(9):e558-e559. - PMID 37567204

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]